Tu, S.-M.; Chen, J.Z.; Singh, S.R.; Aydin, A.M.; Gokden, N.; Tam, N.N.C.; Leung, Y.-K.; Langford, T.; Ho, S.-M.
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care. Cancers 2023, 15, 5533.
https://doi.org/10.3390/cancers15235533
AMA Style
Tu S-M, Chen JZ, Singh SR, Aydin AM, Gokden N, Tam NNC, Leung Y-K, Langford T, Ho S-M.
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care. Cancers. 2023; 15(23):5533.
https://doi.org/10.3390/cancers15235533
Chicago/Turabian Style
Tu, Shi-Ming, Jim Zhongning Chen, Sunny R. Singh, Ahmet Murat Aydin, Neriman Gokden, Neville Ngai Chung Tam, Yuet-Kin Leung, Timothy Langford, and Shuk-Mei Ho.
2023. "Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care" Cancers 15, no. 23: 5533.
https://doi.org/10.3390/cancers15235533
APA Style
Tu, S. -M., Chen, J. Z., Singh, S. R., Aydin, A. M., Gokden, N., Tam, N. N. C., Leung, Y. -K., Langford, T., & Ho, S. -M.
(2023). Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care. Cancers, 15(23), 5533.
https://doi.org/10.3390/cancers15235533